A symmetric geometry of transmembrane domains inside the B cell antigen receptor complex.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
02 07 2019
Historique:
pubmed: 19 6 2019
medline: 31 3 2020
entrez: 19 6 2019
Statut: ppublish

Résumé

B lymphocytes have the ability to sense thousands of structurally different antigens and produce cognate antibodies against these molecules. For this they carry on their surface multiple copies of the B cell antigen receptor (BCR) comprising the membrane-bound Ig (mIg) molecule and the Igα/Igβ heterodimer functioning as antigen binding and signal transducing components, respectively. The mIg is a symmetric complex of 2 identical membrane-bound heavy chains (mHC) and 2 identical light chains. How the symmetric mIg molecule is asymmetrically associated with only one Igα/Igβ heterodimer has been a puzzle. Here we describe that Igα and Igβ both carry on one side of their α-helical transmembrane domain a conserved amino acid motif. By a mutational analysis in combination with a BCR rebuilding approach, we show that this motif is required for the retention of unassembled Igα or Igβ molecules inside the endoplasmic reticulum and the binding of the Igα/Igβ heterodimer to the mIg molecule. We suggest that the BCR forms within the lipid bilayer of the membrane a symmetric Igα-mHC:mHC-Igβ complex that is stabilized by an aromatic proline-tyrosine interaction. Outside the membrane this symmetry is broken by the disulfide-bridged dimerization of the extracellular Ig domains of Igα and Igβ. However, symmetry of the receptor can be regained by a dimerization of 2 BCR complexes as suggested by the dissociation activation model.

Identifiants

pubmed: 31209055
pii: 1907481116
doi: 10.1073/pnas.1907481116
pmc: PMC6613136
doi:

Substances chimiques

Antigens 0
Immunoglobulins 0
Receptors, Antigen, B-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13468-13473

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Annu Rev Biophys Biomol Struct. 1999;28:319-65
pubmed: 10410805
Mol Immunol. 2000 Apr;37(5):253-9
pubmed: 10930632
Immunity. 2000 Jul;13(1):5-14
pubmed: 10933390
Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):880-5
pubmed: 11158564
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2250-5
pubmed: 11226225
Mol Cell. 2002 Nov;10(5):1057-69
pubmed: 12453414
Nat Rev Immunol. 2002 Dec;2(12):945-56
pubmed: 12461567
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3404-8
pubmed: 1373499
Annu Rev Immunol. 1992;10:97-121
pubmed: 1591006
Eur J Med Chem. 2005 Jul;40(7):674-86
pubmed: 15935902
Nat Immunol. 2005 Nov;6(11):1168-76
pubmed: 16200067
Int Immunol. 2006 Sep;18(9):1385-96
pubmed: 16877534
Eur J Immunol. 2007 Jan;37(1):252-60
pubmed: 17163454
Nature. 1991 Aug 29;352(6338):777-81
pubmed: 1881434
Structure. 2010 Aug 11;18(8):934-43
pubmed: 20696394
Nature. 2010 Sep 23;467(7314):465-9
pubmed: 20818374
FEBS Lett. 2010 Dec 15;584(24):4872-7
pubmed: 20920502
Cell. 1990 Oct 19;63(2):381-92
pubmed: 2119890
EMBO J. 1990 Feb;9(2):441-8
pubmed: 2154371
Methods Mol Biol. 2012;813:331-41
pubmed: 22083752
EMBO J. 1990 Feb;9(2):449-55
pubmed: 2303036
Nature. 1990 Feb 22;343(6260):760-2
pubmed: 2304550
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Elife. 2014 Jun 24;3:e02069
pubmed: 24963139
Curr Top Microbiol Immunol. 2016;393:27-43
pubmed: 26428245
EMBO J. 2016 Nov 2;35(21):2371-2381
pubmed: 27634959
EMBO J. 2018 Jun 1;37(11):
pubmed: 29669863
Biol Chem. 2019 Mar 26;400(4):555-563
pubmed: 30465710
Front Immunol. 2018 Dec 17;9:2947
pubmed: 30619307
J Exp Med. 1993 Sep 1;178(3):1049-55
pubmed: 7688784
J Mol Biol. 1993 Feb 5;229(3):602-8
pubmed: 8433362
Biopolymers. 1998 Apr;45(5):381-94
pubmed: 9530015

Auteurs

Cornelia Gottwick (C)

BIOSS Centre For Biological Signaling Studies, Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.

Xiaocui He (X)

BIOSS Centre For Biological Signaling Studies, Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Department of Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.

Andreas Hofmann (A)

BIOSS Centre For Biological Signaling Studies, Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Department of Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.

Niklas Vesper (N)

BIOSS Centre For Biological Signaling Studies, Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.

Michael Reth (M)

BIOSS Centre For Biological Signaling Studies, Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; michael.reth@bioss.uni-freiburg.de jianying.yang@biologie.uni-freiburg.de.
Department of Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.

Jianying Yang (J)

BIOSS Centre For Biological Signaling Studies, Department of Molecular Immunology, Biology III, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; michael.reth@bioss.uni-freiburg.de jianying.yang@biologie.uni-freiburg.de.
Department of Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH